Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GD6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,896
Award facts
- Contract value 100% obligated
- $13,896.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $13,896.27, awards pharmaceutical supplies to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., through the Defense Logistics Agency (DLA). The specific product being delivered is TRELEGY ELLIPTA 200-62.5-25 in a 60-count package—a combination maintenance inhalation powder used for chronic obstructive pulmonary disease management. The award is competitive and non-set-aside, with a firm fixed-price structure and a completion deadline of January 12, 2026. This delivery order is executed under a larger indefinite delivery contract vehicle with the DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's parent organization, Cencora, Inc., maintains the primary indefinite delivery relationship with DLA and holds extensive contracts for supplying a comprehensive range of pharmaceutical products and medical commodities to support defense healthcare operations globally. This delivery order represents one of numerous task orders executed through the broader pharmaceutical supply vehicle, demonstrating AmerisourceBergen's ongoing role in fulfilling essential medication requirements for military treatment facilities and related federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F4GD6?
SPE2DR26F4GD6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F4GD6 worth?
The government has obligated $13,896 on SPE2DR26F4GD6.
Is contract SPE2DR26F4GD6 an order under another contract?
Yes. SPE2DR26F4GD6 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GD6 competed?
The extent of competition for SPE2DR26F4GD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award